Related Experiment Videos

Activated leukocytes, endothelial cells, and effects of pentoxifylline: observations by VEC-DIC microscopy

M Tomita1, Y Fukuuchi, N Tanahashi

  • 1Department of Neurology, School of Medicine, Keio University, Tokyo, Japan.

Insights

Pentoxifylline (PTX) prevents polymorphonuclear leukocyte (PMNL) activation and their damaging interaction with endothelial cells (ECs). This study observed how PTX inhibits PMNLs from adhering to and harming ECs, offering potential therapeutic insights.

Area of Science:

  • Cell Biology
  • Immunology
  • Pharmacology

Background:

  • Polymorphonuclear leukocytes (PMNLs) play a crucial role in inflammatory responses.
  • Endothelial cells (ECs) form the inner lining of blood vessels and are involved in regulating immune cell interactions.
  • The interaction between PMNLs and ECs can lead to tissue damage during inflammation.

Purpose of the Study:

  • To investigate the ultrastructural effects of pentoxifylline (PTX) on polymorphonuclear leukocyte (PMNL) activation and their interaction with endothelial cells (ECs).
  • To observe the dynamic processes of PMNL activation, adhesion to ECs, and subsequent cellular damage.
  • To evaluate the inhibitory effects of PTX on these inflammatory events.

Main Methods:

  • Utilized video-enhanced contrast (VEC)-differential interference contrast (DIC) microscopy for real-time ultrastructural observations.
  • Observed human PMNLs and cultured endothelial cells (human umbilical cord vein endothelial cells, pig, or rat brain ECs).
  • Assessed PMNL activation based on changes in cell shape, granule movement, and adhesiveness; observed interactions in a controlled chamber setting.

Main Results:

  • Spontaneous activation of PMNLs was observed, characterized by shape changes and increased adhesiveness.
  • Pentoxifylline (PTX) pre-administration prevented PMNL activation, maintaining their round shape.
  • Activated PMNLs adhered to ECs, leading to EC shrinkage and coagulation necrosis; PTX treatment de-activated adhered PMNLs, promoting detachment and preventing EC damage.

Conclusions:

  • Pentoxifylline (PTX) effectively inhibits spontaneous and chemoattractant-induced PMNL activation.
  • PTX prevents PMNLs from adhering to and causing damage to endothelial cells (ECs).
  • These findings highlight PTX's potential as a therapeutic agent to mitigate inflammatory tissue damage mediated by PMNL-EC interactions.

Related Concept Videos